Catalyst Wire Dossier Catalyst Wire Dossier

Phrenic nerve stimulator

· Respicardia, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Phrenic nerve stimulator, covering 2014-01-06 to 2014-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing [Phase 1]

See pricing